Phase II study of an intensive combination chemotherapy with cisplatin, adriamycin, etoposide and cyclophosphamide (CAVE) in small cell lung cancer.

J P Sculier; J Klastersky; D Becquart; G Vandermoten; P van Houtte; P Rocmans; J Thiriaux; E Longeval; P Ravez; P Libert

doi:10.1016/s0277-5379(98)90032-3

Phase II study of an intensive combination chemotherapy with cisplatin, adriamycin, etoposide and cyclophosphamide (CAVE) in small cell lung cancer.

Identifier:nobleid.org/w1/20260515/95CFF9BC

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/95CFF9BC.svg?ark=w1%2F20260515%2F95CFF9BC)](https://nobleid.org/work/w1/20260515/95CFF9BC)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Phase II study of an intensive combination chemotherapy with cisplatin, adriamycin, etoposide and cyclophosphamide (CAVE) in small cell lung cancer.

Identifier:nobleid.org/w1/20260515/95CFF9BC

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/95CFF9BC.svg?ark=w1%2F20260515%2F95CFF9BC)](https://nobleid.org/work/w1/20260515/95CFF9BC)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work